With the US and European healthcare industry reaching saturation, emerging markets are being recognized as the growth frontiers of the future, especially in the medical devices market. An affluent consumer base, increasing access to healthcare services and facilities, favorable regulatory scenario and unmet medical needs are encouraging multinational companies and upcoming local players to set up production facilities and sales offices in these markets. MNCs are focusing on improving product offerings in the premium category. Developments in mid-tier products are anticipated to emerge as the new growth wave in the coming years.
The high cost of medical treatment procedures in developed economies has fuelled the popularity of medical tourism. A large number of people seeking medical treatment, including neurovascular surgeries are travelling to developing countries where the cost of medical procedures and therapies are relatively cheaper and more affordable. Besides the lower cost of treatment, several developing countries offer quality healthcare on par with the best in class medical services available in advanced economies. The trend of medical tourism for neurovascular surgeries is therefore expected to drive demand for intracranial stents in the coming years.
As stated by the new market research report on Intracranial Stents, the United States represents the largest market worldwide, followed by Europe. Asia-Pacific, Middle East and Latin America are forecast to spearhead future growth led by rising incidence of stroke, increasing healthcare spending and improving quality of healthcare services.
Key players covered in the report include Admedes Schuessler GmbH, BALT Extrusion, Cardiatis SA, Codman & Shurtleff Inc, Covidien PL
Copyright©2012 Vocus, Inc.
All rights reserved